Skip to content

Irene Murimi-Worstell, PhD, MA

Assistant Professor of Pharmacoepidemiology & Health Policy

Department: School of Pharmacy
Office: MATR 4006J

(P) 617.735.1112


School of Pharmacy


Pharmaceutical Economics and Policy (MS)
Pharmaceutical Economics and Policy (PhD)


BS, Chemical-Biological Engineering, Massachusetts Institute of Technology
MA, Religion (Women, Gender and Sexuality Studies), Yale University
PhD, Pharmaceutical Outcomes and Policy (Pharmacoepidemiology), University of Florida

Research Interests

Evidence Synthesis
Pharmaceutical Access
Global Pharmaceutical Policy
Assessment of the Heterogeneity of Treatment Effects Using Real World Data

Peer-Reviewed Articles & Book Chapters

Irene B. Murimi, Hsien-Yen Chang, Christoper M Jones, Mark Bicket, G. Caleb Alexander. Using Trajectory Models to assess the Effect of Hydrocodone Up-scheduling among Chronic Hydrocodone Users. Pharmacoepidemiology and Drug Safety. 2018. Epub ahead of print.

Irene B. Murimi, Anna Ghambaryan, Robert Decker, Xiaomin Lu, Richard Segal, Nilsa Loyo-Berrios, Danica Marinac-Dabic, Abraham Hartzema. Association between Recombinant Human Bone Morphogenetic Proteins and Post-Operative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity-Score Matched Analysis. World Neurosurgery. 2018. Epub ahead of print.

Hsien-Yen Chang, Irene B. Murimi, Mark Faul, Lainie Rutkow, G. Caleb Alexander. Impact of Prescription Drug Monitoring Programs and Pill Mill Laws on High-Risk Patients. Pharmacoepidemiology and drug safety. 2018 Apr; 27(4):422-9.

Hsien-Yen Chang, Irene B. Murimi, Christopher M Jones, G. Caleb Alexander. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers. Addiction. 2018Apr; 113(4):677-686.